What is the XML declaration required for a “Sequence Listing XML”?
According to MPEP 2413.01(c), the XML declaration required for a “Sequence Listing XML” is: This declaration is specified in WIPO Standard ST.26, paragraph 39(a), and must be included in the “Sequence Listing XML” as per 37 CFR 1.833(b)(2)(i). To learn more: XML declaration Sequence Listing XML WIPO Standard ST.26 patent application biotechnology
Read MoreWhat is WIPO Standard ST.26 and how does it relate to Sequence Listing XML?
WIPO Standard ST.26 is a set of guidelines for the presentation of nucleotide and amino acid sequence listings in patent applications. It is directly related to Sequence Listing XML requirements as specified in MPEP 2413.01(c): The “Sequence Listing XML” presented in accordance with paragraph (a) of this section must further: […] (2) Comply with the…
Read MoreWhere can I find the full text of WIPO Standard ST.26?
The full text of WIPO Standard ST.26 can be accessed through several official sources. MPEP 2412 provides direct links to the standard: 1. WIPO’s official website: www.wipo.int/export/sites/www/standards/en/pdf/03-26-01.pdf 2. USPTO’s Sequence Listing Resource Center: www.uspto.gov/patents/apply/sequence-listing-resource-center/learning-and-resources#standard26 Additionally, MPEP 2412 notes that “WIPO Standard ST.26 is incorporated by reference into the USPTO regulations by including new regulatory text…
Read MoreWhat are the benefits of using WIPO Standard ST.26 for sequence listings?
WIPO Standard ST.26 offers several benefits for sequence listings in patent applications: International Compatibility: It allows for a single, internationally acceptable sequence listing format. Language Neutrality: The format is language-neutral, facilitating use across different countries and regions. Standardization: It uses specified International Nucleotide Sequence Database Collaboration (INSDC) identifiers, ensuring consistency across applications. Efficiency: A single…
Read MoreHow does the validation function in WIPO Sequence work?
The validation function in WIPO Sequence is an integrated feature that helps users identify and correct errors in their sequence listing projects. As described in MPEP 2418: WIPO Sequence includes an integrated validation function that will alert users to most errors in a project or “Sequence Listing XML” data. The validation function generates a report…
Read MoreWhat is the WIPO Sequence tool and how does it help with Sequence Listing XML?
The WIPO Sequence tool is a software application designed to assist patent applicants in generating a compliant “Sequence Listing XML”. According to MPEP § 2413.01(b): “Use of the WIPO Sequence tool will enable a user to generate a ‘Sequence Listing XML’ that conforms to the DTD in Annex II.” This tool helps ensure that the…
Read MoreWhen is a replacement “Sequence Listing XML” required in a patent application?
A replacement “Sequence Listing XML” is required in a patent application under the following circumstances: When errors are identified in a previously submitted “Sequence Listing XML” When the previously submitted “Sequence Listing XML” fails to comply with 37 CFR 1.831 – 1.834 When the applicant chooses to amend a previously submitted “Sequence Listing XML” According…
Read MoreWhat is the WIPO Sequence Validator?
The WIPO Sequence Validator is a tool developed by WIPO for use by Intellectual Property Offices (IPOs) to validate Standard ST.26 “Sequence Listing XML” files. As explained in MPEP 2418: To ensure that IPOs can validate and accept sequence listing projects from applicants generated with WIPO Sequence, WIPO is developing a Standard ST.26 “Sequence Listing…
Read MoreWhat is the WIPO Sequence Tool?
The WIPO Sequence Tool is a desktop application developed by WIPO and adopted by WIPO member states, including the US, to help patent applicants generate compliant “Sequence Listing XML” files. As stated in MPEP 2418: WIPO Sequence has two functions: An authoring function and a validation function. Patent applicants will be able to author and…
Read MoreWhen did the USPTO start requiring Sequence Listing XML for patent applications?
The USPTO began requiring Sequence Listing XML for certain patent applications on July 1, 2022. As stated in MPEP 2419: “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” This requirement applies to patent…
Read More